Erratum to ‘Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma’ [Eur J Cancer 108 (February 2019) 33–40]
Titel:
Erratum to ‘Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma’ [Eur J Cancer 108 (February 2019) 33–40]
Auteur:
Auvray, Marie Auclin, Edouard Barthelemy, Philippe Bono, Petri Kellokumpu-Lehtinen, Pirkko Gross-Goupil, Marine De Velasco, Guillermo Powles, Thomas Mouillet, Guillaume Vano, Yann-Alexandre Gravis, Gwenaëlle Mourey, Loïc Priou, Franck Rolland, Frédéric Escudier, Bernard Albiges, Laurence